SIEMENS HEALTHINEERS AG (SHL.DE) Fundamental Analysis & Valuation
FRA:SHL • DE000SHL1006
Current stock price
33.96 EUR
-1.3 (-3.69%)
Last:
This SHL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SHL.DE Profitability Analysis
1.1 Basic Checks
- In the past year SHL was profitable.
- In the past year SHL had a positive cash flow from operations.
- SHL had positive earnings in each of the past 5 years.
- In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 4.79%, SHL is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
- With a decent Return On Equity value of 11.50%, SHL is doing good in the industry, outperforming 77.59% of the companies in the same industry.
- SHL's Return On Invested Capital of 7.88% is fine compared to the rest of the industry. SHL outperforms 67.24% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 9.41%.
- The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 11.5% | ||
| ROIC | 7.88% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
- Looking at the Profit Margin, with a value of 9.10%, SHL is in the better half of the industry, outperforming 70.69% of the companies in the same industry.
- SHL's Profit Margin has been stable in the last couple of years.
- SHL has a better Operating Margin (13.49%) than 65.52% of its industry peers.
- SHL's Operating Margin has been stable in the last couple of years.
- SHL has a worse Gross Margin (38.44%) than 77.59% of its industry peers.
- SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.49% | ||
| PM (TTM) | 9.1% | ||
| GM | 38.44% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. SHL.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
- SHL has less shares outstanding than it did 1 year ago.
- SHL has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for SHL has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.82 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
- SHL's Altman-Z score of 1.82 is on the low side compared to the rest of the industry. SHL is outperformed by 63.79% of its industry peers.
- SHL has a debt to FCF ratio of 6.56. This is a slightly negative value and a sign of low solvency as SHL would need 6.56 years to pay back of all of its debts.
- SHL has a Debt to FCF ratio (6.56) which is comparable to the rest of the industry.
- SHL has a Debt/Equity ratio of 0.53. This is a neutral value indicating SHL is somewhat dependend on debt financing.
- SHL has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: SHL underperforms 63.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 6.56 | ||
| Altman-Z | 1.82 |
ROIC/WACC1.28
WACC6.14%
2.3 Liquidity
- SHL has a Current Ratio of 1.04. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
- SHL has a Current ratio of 1.04. This is in the lower half of the industry: SHL underperforms 74.14% of its industry peers.
- A Quick Ratio of 0.72 indicates that SHL may have some problems paying its short term obligations.
- The Quick ratio of SHL (0.72) is worse than 72.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.04 | ||
| Quick Ratio | 0.72 |
3. SHL.DE Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 1.33% over the past year.
- Measured over the past years, SHL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.29% on average per year.
- SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.76%.
- SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.08% yearly.
EPS 1Y (TTM)1.33%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%-21.57%
Revenue 1Y (TTM)2.76%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-1.46%
3.2 Future
- Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.02% on average per year.
- SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.77% yearly.
EPS Next Y-2.64%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
EPS Next 5Y8.02%
Revenue Next Year1.79%
Revenue Next 2Y3.93%
Revenue Next 3Y4.65%
Revenue Next 5Y4.77%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. SHL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 14.89, SHL is valued correctly.
- Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 89.66% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of SHL to the average of the S&P500 Index (26.91), we can say SHL is valued slightly cheaper.
- SHL is valuated correctly with a Price/Forward Earnings ratio of 12.82.
- Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 79.31% of the companies are valued more expensively.
- SHL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.99.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 12.82 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 65.52% of the companies listed in the same industry.
- 79.31% of the companies in the same industry are more expensive than SHL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.14 | ||
| EV/EBITDA | 11.59 |
4.3 Compensation for Growth
- The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.32
EPS Next 2Y5.26%
EPS Next 3Y7.63%
5. SHL.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.78%, SHL has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.30, SHL pays a better dividend. On top of this SHL pays more dividend than 84.48% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, SHL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.78% |
5.2 History
- The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
- SHL pays out 50.31% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50.31%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
SHL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:SHL (4/29/2026, 2:18:06 PM)
33.96
-1.3 (-3.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength42.57
Industry Growth70
Earnings (Last)02-05 2026-02-05/dmh
Earnings (Next)05-07 2026-05-07
Inst Owners13.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap38.31B
Revenue(TTM)23.30B
Net Income(TTM)2.12B
Analysts79.29
Price Target54.21 (59.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.78% |
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP50.31%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.86%
Min EPS beat(2)-13.74%
Max EPS beat(2)-3.98%
EPS beat(4)1
Avg EPS beat(4)-1.6%
Min EPS beat(4)-13.74%
Max EPS beat(4)13.36%
EPS beat(8)4
Avg EPS beat(8)1.31%
EPS beat(12)6
Avg EPS beat(12)0.88%
EPS beat(16)9
Avg EPS beat(16)1.56%
Revenue beat(2)1
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)0.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.11%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)0.27%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.67%
Revenue beat(16)7
Avg Revenue beat(16)-0.39%
PT rev (1m)-1.5%
PT rev (3m)-4.23%
EPS NQ rev (1m)-2.14%
EPS NQ rev (3m)-8.05%
EPS NY rev (1m)0.75%
EPS NY rev (3m)-1.92%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-2.11%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 12.82 | ||
| P/S | 1.64 | ||
| P/FCF | 17.14 | ||
| P/OCF | 12.58 | ||
| P/B | 2.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.59 |
EPS(TTM)2.28
EY6.71%
EPS(NY)2.65
Fwd EY7.8%
FCF(TTM)1.98
FCFY5.83%
OCF(TTM)2.7
OCFY7.95%
SpS20.65
BVpS16.34
TBVpS-4.52
PEG (NY)N/A
PEG (5Y)1.32
Graham Number28.9504 (-14.75%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 11.5% | ||
| ROCE | 10.26% | ||
| ROIC | 7.88% | ||
| ROICexc | 8.62% | ||
| ROICexgc | 53.82% | ||
| OM | 13.49% | ||
| PM (TTM) | 9.1% | ||
| GM | 38.44% | ||
| FCFM | 9.59% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 6.56 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 62.76% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | 7.31 | ||
| Cash Conversion | 68.7% | ||
| Profit Quality | 105.47% | ||
| Current Ratio | 1.04 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 1.82 |
F-Score7
WACC6.14%
ROIC/WACC1.28
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)1.33%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%-21.57%
EPS Next Y-2.64%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
EPS Next 5Y8.02%
Revenue 1Y (TTM)2.76%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-1.46%
Revenue Next Year1.79%
Revenue Next 2Y3.93%
Revenue Next 3Y4.65%
Revenue Next 5Y4.77%
EBIT growth 1Y7.86%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year31.85%
EBIT Next 3Y17.07%
EBIT Next 5Y12.82%
FCF growth 1Y40.04%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y28.66%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE Fundamental Analysis FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
Can you provide the valuation status for SIEMENS HEALTHINEERS AG?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
What is the profitability of SHL stock?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
What is the earnings growth outlook for SIEMENS HEALTHINEERS AG?
The Earnings per Share (EPS) of SIEMENS HEALTHINEERS AG (SHL.DE) is expected to decline by -2.64% in the next year.
Is the dividend of SIEMENS HEALTHINEERS AG sustainable?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 7 / 10 and the dividend payout ratio is 50.31%.